retatrutide triple agonist weight loss trial Lilly orforglipron oral GLP-1 phase 3 Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Description
The terms are strict
Phase 2 clinical trial results for retatrutide in obesity
Sources Retatrutide discovery paper (Cell Metabolism) Cell Metabolism Phase 1b PK study (Lancet) The Lancet Related reading Retatrutide Dosage & Dosing Guide: Titration, Missed Doses, Taper Phase 3 titration schedule (246912 mg), missed-dose protocol, taper guidance, and dose-by-dose weight loss data
Dietary fiber is a type of carbohydrate and is found only in plant foods
GIPR, glucose-dependent insulinotropic peptide receptor
